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Incidence and frequency
rates of childhood cancer
in Namibia
Glynn Wessels, Peter B Hesseling
Objective. To estimate the extent of paediatric malignancy
in an African country and to compare these findings wjth
paediatric cancer rates in other countries.
Design. A retrospective descriptive study which
calculated incidence and frequency rates from the data
obtained from a 6-year survey of childhood cancer in
Namibia.
Setting. Children from the general community who were
referred by primary care physicians or clinics and
diagnosed in peripheral district hospitals or a tertiary care
institution.
Patients. A total of 163 children less than 15 years of
age diagnosed with any malignant neoplasm, intracranial
tumour or histiocytosis between 1983 and 1988.
Intervention. None_
Main outcome measures. The minimum overall
incidence of childhood cancer recorded in Namibia was
lower than the rates usually reported by economically
privileged countries. The rates of certain malignancies
corresponded to the rates recorded in other African
countries.
Results. The overall incidence of childhood cancer was
55.5 per million. Tumours of the central nervous system
occurred most commonly (18%), followed by renal
tumours (14%), leukaemia (12%) and lymphoma <11.5%).
The 5.8 per million incidence rate of retinoblastoma was
similar to the rates recorded in other African countries but
higher than in the UK or the USA. The incidence rates per
million children for renal tumours, malignant bone tumours
and soft-tissue sarcomas were 7A, 4.8 and 5.2,
respectively, which correspond with the rates in Western
Europe and the USA. The incidence rate of eNS tumours
was only 9.3 per million. Both leukaemia (6.5 per million)
and lymphoma (6.3 per million) had rates far lower than
those recorded in central Africa or developed Western
countries.
Conclusion. The incidence pattern of childhood cancer
in Namibia demonstrates features of both the patterns
described as typical for Africa and those described for
industrialised countries.
S Air Med J 1997; 87; 885-889.
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In the report by Parkin l on the worldwide occurrence of
paediatric cancer, the data of ten registries from Africa were
included. The majority of these registries made use of
relative frequency rates to estimate cancer frequency, and
incidence rates could be calculated only for the registries of
Sulawayo (Zimbabwe)/ Ibadan (Nigeriap and Kampala
(Uganda).4 The registries demonstrated a wide variation in
the occurrence of childhood cancer in Africa. The incidence
of paediatric malignancies in the majority of African
countries, however, remains unknown. The purpose of this
paper is to report the incidence of Childhood cancer in
Namibia for the period January 1983 to December 1988.
Methods
During the 6-year period from January 1983 to December
1988 a survey of paediatric cancer in Namibian children was
undertaken to provide the basis for a population-based
childhood tumour registry. The study population consisted of
all children resident in Namibia during the survey. Any child
less than 15 years of age with a diagnosis of any malignant
neoplasm, intracranial tumour or histiocytosis was eligible for
registration. Tumours were coded according to the
International Classification of Diseases for Oncology (/C~O)5
and classified as proposed by Birch and Marsden.6 Name,
age, sex, date of birth, ethnic group, address, diagnosis and
diagnosis date were considered essential infonnation to be
recorded for each patient whenever possible. Date of
diagnosis was the date that the patient first presented with
clinical symptoms related to the malignancy or, when this was
unknown, the date that the diagnosis was recorded. Many of
the children with cancer were referred to Tygerberg Hospital
for treatment during the survey period. The data on these
children were available in the Tygerberg children's tumour
registry and were included in a previous repore In a further
attempt to maximise ascertainment, regular contact with all
other paediatric cancer units in South Africa was maintained
to ensure awareness of any cases referred to these units from
Namibia. The investigators also personally scrutinised the
clinical records of all district, central and referral hospitals in
Namibia for previously unrecorded patients with proven or
clinically suspected malignancies. The former were included
and every effort was made by means of personal home visits
or visits by other medical and/or nursing staff or social
workers to establish the clinical course and health status of
patients in the latter group. The only pathology laboratory in
Namibia dUring the survey was the state pathology laboratory
in Windhoek, the capital city, which served as a referral centre
for all of Namibia. The records of this laboratory were made
available to the investigators so that they could search for
unrecorded cases. Contact was also made with medical
practitioners in rural areas as well as health personnel in
peripheral clinics, and messages were broadcast on the radio
in an attempt to verify and contact all children with cancer.
The calculated average childhood population during the 6
years of the survey was 495 689. This figure was obtained
by using the data of the 1981 national census and assuming
a 3% annual increase in the population to allow for births
and deaths.8 This growth rate was recommended by the
Directorate: Development Co-ordination SWA for statistical
purposes, and was derived from the average growth rate
which had been recorded since the previous population
census in 1970. The mean childhood populations for the
age groups 0,1 - 4, 5 - 9 and 10 - 14 years were 32 220,
141 767, 169 526 and 152 176, respectively.
Incidence and relative frequency rates were calculated for
all the malignancies as well as for the age groups 0, 1 - 4,
5 - 9 and 10 - 14 years. The mean and median ages of
patients were calculated for the individual tumour groups.
Incidence rates were standardised according to the direct
method using the world standard population as the
reference population.s.lo The age-standardised cancer ratio
to adjust relative frequency was calculated by use of the
standard population as used by Parkin et al. I When
incidence rates were statistically compared, indirect
standardisation and calculation of the standardised
incidence ratio (SIR) were undertaken.sThe total age-
specific incidence rates were used as the reference
popUlation for calCUlating the SIRs to evaluate differences in
the individual age groups. Two-sided statistical tests were
used to determine the significance of the SIRs.
Results
The 163 tumours that were recorded represent an overall
annual incidence of 55.5 per million population. The total
number, relative frequency and incidence rates of the
recorded tumours are listed in Table I. Because of the small
number of tumours recorded, results for boys and girls and
age-specific rates for individual diagnostic groups are not
presented separately. Ninety-one per cent of the 163 tumours
were histologically verified, which included bone marrow
examinations on all but 2 of the leukaemia patients who were
diagnosed on the basis of the presence of numerous blast
cells on a peripheral smear. Ten brain tumours and 2
sympathetic nervous system tumours were diagnosed by
clinical, laboratory and radiological investigation.
Brain and spinal cord tumours occurred most commonly,
followed by renal tumours, lymphomas and leukaemias.
Despite the high relative frequency rates of these tumours,
only the renal tumours had an incidence comparable to the
rates recorded in developed Western countries (Table 11).
Sixteen of the 19 leukaemia patients had acute lymphocytic
leukaemia (ALL) with a ratio of AWacute non-lymphocytic
leukaemia of 0.2. Neuroblastoma (NB) comprised 9.3% of all
tumours, only slightly less than the frequencies of 10.5% and
9.5% recorded for retinoblastomas (RSs) and soft-tissue
sarcomas (STSs), respectively. NB and RB had high incidence
rates relative to those in Uganda and developed Westem
countries, respectively.~·"·12 The recorded incidence rates of
the main diagnostic groups are compared with the rates of
three African countries, the USA and the UK in Table 11.
Tumours occurred with equal frequency in both sexes. Of
163 registered patients, 88 were boys and 75 girls, a ratio of
, .2. The mean age of all the patients was 7.2 years (median
7 years), 6.9 years (median 7 years) for boys and 7.5 years
(median 7.25 years) for girls. The overall age-specific
incidence rates of the tumours in the age groups 0 years,
1 - 4 years,S - 9 years and 10 - 14 years were 57 per
million, 59 per million, 42 per million and 63 per million,
respectively. The lowest incidence rate in the 5 - 9-year age
group did not differ statistically from the rates recorded in
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Table I. Total number. relative frequency and incidence rates of tumours recorded in Namibia, 1983· 1988
Relative frequency (%) Rates per million
Diagnostic group No. of cases Crude Adjusted Crude Adjusted
Leukaemias 19 11.7 11.6 6.4 6.5
Lymphomas 19 11.7 11.5 6.4 6.3
CNS 28 17.2 17.8 9.4 9.3
Sympathetic NS 14 8.6 9.3 4.7 5.2
Retinoblastoma 16 9.8 10.5 5.4 5.8
Renal tumours 21 12.9 13.8 7.1 7.4
Uver tumours 1 0.6 0.6 0.3 0.4
Bone tumours 15 9.2 8.1 5.0 4.8
Soft-tissue sarcomas 16 9.8 9.5 5.4 5.2
Gonadal and germ cell 3 1.8 1.7 1.0 1.0
Epithelial neoplasms 4 2.5 2.2 1.3 1.3
Other 7 4.3 3.5 2.4 2.3
-
-
--
Total 163 100 100 55 55.5
Table 11. Incidence rates (per million) in Namibia and other countries
Countries
Diagnostic groups Namibia Zimbabw& U9anda' Nigeria3 USA'" UKt 2
Leukaemias 6.5 16.0 14.4 11.5 24.1 38.3
Lymphomas 6.3 14.5 27.9 96.5 9.8 12.3
Brain and eNS 9.3 14.7 4.2 5.0 21.3 25.8
Sympathetic NS 5.2 8.0 1.7 6.0 8.8 7.7
Retinoblastoma 5.8 5.9 7.1 7.6 4.3 2.2
Renal tumours 7.4 8.2 8.0 10.8 11.0 7.0
Hepatic tumours 0.4 0.6 2.2 1.0 1.0
Malignant bone tumours 4.8 2.0 7.5 2.8 4.8 4.4
Soft-tissue sarcomas 5.2 8.7 8.0 8.7 7.7 5.0
Gonadal and germ cell 1.0 2.3 2.1 0.6 3.9 4.4
Epithelial tumours 1.3 4.4 7.7 1.9 4.5 2.4
Other 2.3 1.7 1.7 2.9 0.6
--
Total 55.5 84.7 90.9 155.5 104.1 111.1
Table 111. Evaluation of tumour occurrence in four age groups in
boys and girls by SIRs
the other age groups. Comparison of tumour occurrence in
boys, girls and all patients in the standard age groups is
shown in Table Ill.
Age group Exp 1 Obs2 SIR P-value
The median ages of patients with sympathetic nervous
system tumours, retinoblastoma and renal tumours were 2.4,
3 and 3.5 years, respectively. This was significantly lower
than the median ages of children diagnosed with leukaemias
(9.5 years), lymphomas (8 years), central nervous system
(CNS) tumours (7.8 years), bone tumours (12 years) and
STSs (13 years).
Exp 1 '" expected number of cases; Obs 2 ,. observed numbef of cases: NS '" not
significant (P > O.CS).
Tumour distribution by age group in all children
o 10.6 11 103.8 NS
1 - 4 46.8 50 106.8 NS
5 - 9 55.9 43 76.9 NS
10-14 50.2 59 117.5 NS
Tumour distribution by age group in boys
o 6~ 7
1 - 4 24.8 26
5-9 30.3 25
10 - 14 26.9 30
Tumour distribution by age group in girls
o 4B 4
1 - 4 21.5 24
5 - 9 25.2 18
10-14 22.9 29
116.7
104.8
82.5
111.5
81.6
111.6
71.4
126.6
NS
NS
NS
NS
NS
NS
NS
NS
Discussion
Relative frequency rates and cancer ratios are unsuitable for
the comparison of cancer occurrence between different
registries or countries as the increased incidence of one
cancer will influence the relative frequency rate of another
cancer. Incidence rates that use population-based data,
obtained from population-based tumour registries or surveys
that have been recorded in an unbiased way, are a better
indication of the real frequency of tumour occurrence.'J In
this survey we attempted to record in an unbiased fashion
all tumours that occurred in Namibian children under 15
years of age over a 6-year period.
The overall recorded tumour incidence of 55 per million is
about half the minimum incidence recorded worldwide.l~
This low overall rate is probably due to a failure to diagnose
all the malignancies that occurred during the survey.
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Incomplete ascertainment of tumours may have been due to
the failure of health workers to diagnose a malignancy
because of inexperience in recognising a childhood
malignancy, or because of the difficulty in distinguishing
between the overlapping symptomatology of cancer and
commonly occurring infectious conditions such as malaria or
tuberculosis. Atternatively, the low incidence rates may be
due to pre-emptive deaths caused by infectious or
nutritional disease. It is also possible that the undiagnosed
child may never have attended a regular medical service,
either because of parental reluctance to take the child to
such a service or because of the physical inaccessibility of
health care. The child may also have been referred to a
health service not committed to register cancer patients.
Ninety-one per cent of the tumours in this survey were
histologically verified. This is a very high proportion for a
developing country and may indicate a failure to register
some clinically diagnosed cases. A search through the
clinical records of all district hospitals and systematic
questioning of medical personnel at peripheral clinics as well
as medical practitioners in rural areas, however, did not
confirm this suspicion. All practising paediatricians in
Namibia were members of staff of the Windhoek state
referral hospital during the study. It is therefore unlikely that
any oncology patients were privately treated or referred
elsewhere, without the knowledge of the investigators.
Regular contact with paediatric cancer units in South Africa
failed to identify any cases not recorded in this registry.
The Namibian children's tumour registry can attempt to
improve ascertainment by the regUlar scrutiny of all
diagnostic sources that were identified during the survey.
These are mainly the records of the govemment pathology
service in Windhoek, and the records of the adult oncology
clinic at Central Windhoek Hospital. which sometimes treats
patients younger than 15 years of age. Education of primary
heatth care workers to suspect childhood cancer should
improve ascertainment.
There was no difference in the mean or median ages of
male and female patients. The male/female ratio of 1.2 was
largely the result of an excess number of boys with
lymphoma (ratio 2.8). This male predominance is in keeping
with international trends. '4 More boys than girls were
diagnoSed with malignant bone tumours. The male/female
ratio was 2.0 in contrast to reports in the literature that show
higher rates in girls,'.c especially in the 10 -14-year age
group where the incidence rates of osteosarcomas vary from
approximately 5 to 10 per million and 4 to 7.5 per million for
girls and boys, respectively.
Tumours occurred with equal frequency in all the age
groups in boys. in girls and in the combined group. It should
be noted that although the SIR in the four age groups did
not differ slatis~cally, the value of 117.5 for all children aged
10 - 14 years and 126.6 for all girls aged 10 - 14 years did
indicate a possible increased frequency of tumours in older
children and especially in older girls. Children in Europe, the
UK and the USA usually have the highest rate recorded in
children less than 4 years of age.t2.1~lBwhile tumours occur
more frequently in older children (10 -14 years) in African
countries.:J..C The characteristic occurrence of NB. RB and
renal tumours in young children in other countries'· was also
found in Namibia. The mean age of all leukaemia patients in
Namibia, however, was 8 years. The peak in incidence of
ALL in the 2 - 4-year age group. which is usually reported in
developed countries, was absent. The mean age and age
distribution for leukaemia. lymphoma, tumours of the eNS
and STS did not differ from the recorded pattern of
occurrence in developing countries.
The pattern. incidence and frequency rates of cancer in
Namibian children demonstrate both interesting similarities
to and differences from other African countries, the UK and
the USA.2.... '''2 The relative frequency rates of RB. STS. renal
tumours and bone tumours correspond to the pattern of
increased frequency that is found in other countries in Africa
and in black Americans, relative to white populations.
The 5.8 per million incidence rate of RB in Namibian
children is lower than the rates of 7.1 per million and 7.6 per
million recorded in Uganda and Nigeria, respectively,3,~ but
higher than the 4.3 per million recorded in the USA and the
2.2 per million in the UK.11 '2 Laterality was recorded in all the
patients and bilateral tumours occurred in 25% of cases.
The mean age at diagnosis was 3 years and no family
history of RB could be obtained in any of the patients. The
relatively high incidence of RB and the presentation at an
older age in Namibian and other children in Africa may
suggest an environmental influence for this type of tumour.
Further studies are needed to elucidate this hypothesis. The
recorded incidence rate of 4.8 per million for bone tumours
corresponds to rates recorded in developed countries and is
higher than the recorded rates of African countries with the
exception of ·Uganda, which has an incidence of 7.5 per
million. The majority of tumours were osteosarcomas and
the ratio of EWing's sarcoma to osteosarcoma was 0.17.
These relatively high incidence rates of RB and malignant
bone tumours become more significant when the low total
incidence of childhood cancers recorded in Namibia is taken
into account.
Tumours of the central and sympathetic nervous systems
occurred more frequently than in most African countries.'··H!i
This high relative frequency and incidence rate of brain
tumours in Namibia are of special interest when the low
rates that were previously accepted as typical of children
from African countries are considered. Although tumours of
the eNS occurred more frequently in Namibia than either
leukaemia or lymphoma, the incidence rate of 9.3 per million
is still less than half the rate recorded in developed countries
(Table 11). Although the low incidence of brain tumours in
other sub-Saharan countries may reflect a true low
incidence. our data suggest that many CNS tumours have
previously not been recorded in Africa. This may have been
due to the scarcity of modern diagnostic imaging facilities or
to the non-recording of eNS tumours because of the
inability to treat these patients. A low frequency of NB
appears to be confined to East African countries.H " The
incidence of this tumour in Namibia corresponds to the rates
recorded in Zimbabwe and Nigeria.
Despite the low overall incidence rate, some tumour groups
were diagnosed with a frequency similar to those in
developed countries. which have sophisticated and long-
standing registries. If the incidence rates for American
children are accepted as a reasonable norm for Namibia,11 a
variation in the completeness of ascertainment for different
diagnostic categories is apparent. This indicates either
selective complete ascertainment of some tumour groups or.
if underdiagnosis applies to all tumour categories, that certain
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tumours in Namibia have an incidence in excess of the rates
usually reported in the literature_ AB and malignant bone
tumours appear to be the tumour groups with the highest
incidence rates in relation to other countries while leukaemias
and lymphomas constitute the main underdiagnosed cancers
and also to a lesser extent, brain tumours. No reason was
found for this possible selective underdiagnosis. Pre-emptive
deaths in the leukaemic age group and similarity of
symptoms in leukaemias, lymphomas and infectious diseases
possibly contribute to underascertainment in these tumour
groups. No reason could be found for the high incidence of
AB and malignant bone tumours. These tumours were
diagnosed mainly in children from the rural areas so that
proximity to medical facilities did not account for the
increased ascertainment of AB or bone tumours relative to
other tumour groups. This high frequency of AB and bone
tumours needs to be confirmed by ongoing tumour
registration. The incidence of renal tumours in Namibia and
other African countries does not vary significantly from the
rates recorded in the majority of Western countries.
The pattern of childhood cancer in Namibia corresponds
to that of industrialised countries for some disease
categories, but demonstrates both similarities to and
marked differences from previous reports on childhood
cancer from countries in Africa.
We thank the Harry Crossley Foundation and the Cancer
Association of Namibia.
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Illicit intravenous drug use
in Johannesburg -
medical complications and
prevalence of HIV infection
P G Williams, S M Ansell, F J Milne
Objective. To describe the magnitude of the problem of
abuse by self-injection of dipianone HCI/cyclizine Hel
(Wellconal) and to document the associated morbidity,
mortality and prevalence of HIV infection.
Design. We conducted a retrospective analysis of 121
admissions of 86 patients who were current intravenous
Wellconal abusers and presented to Johannesburg and
J G Strijdom Hospitals over an 18-month period_ Case
records were analysed in respect of age, sex, median
hospital stay, complications, HIV antibody status and
eventual outcome.
Main outcome measures. Age, sex, median hospital stay,
complications, HIV antibody status and eventual outcome.
Results. Complications of Wellconal abuse occurred in
young adults (median age 24 years) with an approximately
equal gender distribution. Opiate overdose was the most
frequent presenting diagnosis (32%), followed by right-
sided endocarditis (20%) and deep-vein thrombosis (12%).
A wide variety of complications accounted for the
remaining 36%. A 2% HIV antibody positivity rate was
found, which is substantially lower than that encountered
in intravenous drug abusers in other parts of the world.
Seventy-eight per cent of patients completed therapy
successfUlly, but 19% left hospital prematurely against
medical advice. There was a mortality rate of 3%.
Conclusions. While the prevalence of Wellconal abuse in
the broader South African community is unknown, our
study draws attention to the extent of the problem in
Johannesburg.
S Afr Med J 1997; 87: 889-891.
Illicit intravenous self-injection of proprietary drugs and other
substances is a common problem worldwide. In the USA
there are an estimated 1.1 - 1.8 million illicit drug injectors.1
A recent review documented the changing patterns of abuse
and complications in the USA.2 Levels of HIV seropositiVity
exceeding 30 - 40% and the attendant increased mortality
rate are also well shown.3ot Local patterns of abuse,
complications and HIV seropositivity,s which appear to differ
Department of Medicine, University of the Witwatersrand.
Johannesburg
P G Williams. MB BCh. OTWH FCP (SAl
S M Ansell. MS OlB. Q1M&ZoI. PhD
F J Milne MO. Fa' (SA)
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